cripowellin B: from Crinum powellii; structure in first source
Flora | Rank | Flora Definition | Family | Family Definition |
---|---|---|---|---|
Crinum | genus | A plant genus of the family Amaryllidaceae that contains ALKALOIDS.[MeSH] | Amaryllidaceae | A family of herbaceous plants with bulbs or rhizomes in the order Asparagales.[MeSH] |
ID Source | ID |
---|---|
PubMed CID | 10720831 |
CHEMBL ID | 3890244 |
SCHEMBL ID | 14260338 |
MeSH ID | M0492847 |
Synonym |
---|
SCHEMBL14260338 |
cripowellin b |
CHEMBL3890244 |
(1r,14s,15r)-14-hydroxy-15-[(2r,3r,4s,5r,6r)-6-(hydroxymethyl)-3,4,5-trimethoxyoxan-2-yl]oxy-5,7-dioxa-12-azatetracyclo[10.5.2.02,10.04,8]nonadeca-2,4(8),9-triene-13,17-dione |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID1321907 | Antiplasmodial activity against chloroquine/mefloquine-resistant Plasmodium falciparum Dd2 measured after 72 hrs by SYBR Green1-based fluorescence assay | 2016 | Bioorganic & medicinal chemistry, 11-01, Volume: 24, Issue:21 | New potently bioactive alkaloids from Crinum erubescens. |
AID1321909 | Antiproliferative activity against human A2780 cells measured after 2 days by AlamarBlue assay | 2016 | Bioorganic & medicinal chemistry, 11-01, Volume: 24, Issue:21 | New potently bioactive alkaloids from Crinum erubescens. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.87) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |